The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord

General Pharmacology

Volumn 28, Issue 5, 1997, Pages 633-638

  Dickenson, A H ^a   Chapman, V ^a   Green, G M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

c fos; GABA; glutamate; LTP (long term potentiation); NMDA; Nociception; spinal cord

Indexed keywords

EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANTINOCICEPTION; DRUG EFFECT; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; HYPERSENSITIVITY; LONG TERM POTENTIATION; NOCICEPTIVE STIMULATION; NONHUMAN; ONCOGENE C FOS; PAIN; PRIORITY JOURNAL; REVIEW; SPINAL CORD DORSAL HORN; STIMULUS RESPONSE;

ANIMALS; EXCITATORY AMINO ACIDS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; HYPERALGESIA; NEURAL INHIBITION; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0030974434     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00359-X     Document Type: Review

References (62)

1. Barnard E. and Henley J. M. (1990) The non-NMDA receptors: Types, protein structure and molecular biology. Trends Pharm. Sci. 11, 500-507.
2. Bashir Z. I. and Collingridge G. L. (1992) Synaptic plasticity: Long term potentiation in the hippocampus. Curr. Opin. Neurobiol. 2, 328-335.
3. Battaglia G. and Rustioni A. (1988) Coexistence of glutamate and substance P in dorsal root ganglion cells of the rat and monkey. J. Comp. Neurol. 277, 302-312.
4. Bennett G. J. (1994) Animal models of neuropathic pain In Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management (Vol. 2) (Edited by Gebhart G. F., Hammond D. L. Jensen T.), pp. 495-510. IASP Press, Seattle, WA.
5. Bernardi P, S., Valtschanoff J. G., Weinberg R. J., Schmidt H. H. H. W. and Rustioni A. (1995) Synaptic interactions between primary afferent terminals and GABA and nitric oxide-synthesizing neurons in superficial laminae of the rat spinal cord. J. Neurosci. 15, 1363-1371.
6. Besson J, M. and Chaouch A. (1987) Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67, 67-186.
7. B receptor mediated events to inflammatory pain processing: Carrageenan oedema and associated spinal c-Fos expression, Neuroscience. 73, 487-496.
8. Castro-Lopes J. M., Tavares I. and Coimbra A. (1993) GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res. 620, 287-291.
9. Castro-Lopes J. M., Tavares I., Tolle T. R. and Coimbra A. (1994) Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in the rat spinal cord that is prevented by peripheral neurectomy or neonatal capsaicin treatment. Pain 56, 193-201.
10. Chapman V. and Dickenson A. H. (1992) The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573, 321-323.
11. Chapman V., Honoré P., Buritova J. and Besson J. M. (1995) The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain. Br. J. Pharmac. 116, 1628-1634.
12. Coderre T. J. and Melzack R. (1992) The contribution of excitatory amino-acids to central sensitization and persistent nociception after formalin-induced tissue injury. J. Neurosci 12, 3665-3670.
13. Clavier N., Lombard M.-C. and Besson J.-M. (1992) Benzodiazepines and pain: Effects of midazolam on the activities of nociceptive non-specific dorsal horn neurons in the rat spinal cord. Pain 48, 61-71.
14. B receptors on Aδ and C primary afferents. Br. J. Pharmac. 81, 327-333.
15. Dickenson A. H. (1994a) NMDA receptor antagonists as analgesics (Edited by Fields H. L. and Liebeskind J. C.), pp. 173-187. Progress in Pain Research and Management. IASP Press, Seattle, WA.
16. Dickenson A. H. (1994b) Where and how opioids act In Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management (Vol. 2) (Edited by Gebhart G. F., Hammond D. L. and Jensen T.), pp. 525-552. IASP Press, Seattle, WA.
17. Dickenson A. H. and Aydar E. (1991) Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci. Lett. 121, 263-266.
18. Dickenson A. H., Brewer C. M. and Hayes N. A. (1985) Effects of topical baclofen on C fibre-evoked neuronal activity in the rat dorsal horn. Neuroscience 14, 557-562.
19. Dickenson A. H. and Sullivan A. F. (1987) Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 83, 207-211.
20. Dirig D. M. and Yaksh T. L. (1995) Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J. Pharmac. Exp. Ther. 275, 219-227.
21. Eide P. K., Jorum E., Stubhaug A., Bremnez J. and Breivik H. (1994) Relief of post-herpetic neuralgia with the N-methyl-D-aspartate receptor antagonist ketamine: A double blind, cross-over comparison with morphine and placebo. Pain 58, 347-354.
22. Eisenberg E., LaCross S. and Strassman A. M. (1994) The effects of the clinically tested NMDA receptor antagonist memantine on carrageenin-induced thermal hyperalgesia in rats. Eur. J. Pharmac. 255, 123-129.
23. Elliot K. J., Brodsky M., Hyansky A., Foley, K. M. and Inturissi C. E. (1994) Dextromethorphan suppresses the formalin-induced increase in c-Fos mRNA. Am. Soc. Neurosci. Abstr. 568.15.
24. Gracely R., Lynch S. A., Bennet G. J. (1993) Painful neuropathy: Altered central processing maintained dynamically by peripheral input. Pain 52, 251-253.
25. Haley J. E., Sullivan A. F. and Dickenson A. H. (1990) Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518, 218-226.
26. Henry J. L. (1982) Pharmacological studies on the prolonged depressant effects of baclofen on lumber dorsal horn units in the cat. Neuropharmacology 21, 1085-1093.
27. Hunter J. C. and Singh L. (1994) Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat. Neurosci. Lett. 174, 217-221.
28. Johnston G. A. R., Hailstone M. H. and Freeman C. G. (1980) Baclofen; stereoselective inhibition of excitatory amino acid release. J. Pharm. Pharmac. 32, 230-231.
29. Kayser V. (1994) Endogenous opioid systems in the modulation of pain: Behavioural studies in rat models of persistent hyperalgesia In Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management (Vol. 2) (Edited by Gebhart G. F., Hammond D. L. and Jensen T.), pp. 553-568. IASP Press, Seattle, WA.
30. Kehl L. J., Gogas K. R., Lichtblau L., Pollack C. H., Mayes M., Basbaum A. I. and Wilcox G. L. (1991) The NMDA antagonist MK801 reduces noxious stimulus-evoked FOS expression in the spinal cord dorsal horn In Proceedings of the IVth World Congress on Pain. (Edited by Bond, Charlton and Woolf), p. 307. Elsevier, Amsterdam.
31. Kombain S. B. and Malenka R. C. (1994) Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature 368, 242-246.
32. Malcangio M. and Bowery N. (1994) Spinal cord SP release and hyperalgesia in monoarthritic rats; involvement of the GABA B receptor system. Br. J. Pharmac. 113, 1561-1566.
33. Manzoni O. J., Manabe T. and Nicoll R. A. (1994) Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265, 2098-2101.
34. Mao J., Price D. D., Hayes R. L., Lu J., Mayer D. J. and Frenk H. (1993) Intrathecal treatment with dextrophan or ketamine potently reduces pain related behaviours in a rat model of peripheral mononeuropathy. Brain Res. 605, 164-168.
35. Mayer M. L. and Westbrook G. L. (1987) Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J. Physiol. (Lond) 394, 501-527.
36. Millan M. J. and Segiun L. (1994) Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice. Neurosci. Lett. 178, 139-143.
37. Morgan J. I. (1991) Discussions in Neuroscience, Proto-Oncogene Expression in the Nervous System (Vol. VII, No. 4). Elsevier, Amsterdam.
38. Price D. D., Mao J., Frenk H. and Mayer D. J. (1994) The N-methyl-D-aspartate antagonist dextromethorphan selectively reduces temporal summation of second pain. Pain 59, 165-174.
39. Reeve A. J. and Dickenson A. H. (1995) The roles of adenosine in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br. J. Pharm. 116, 2221-2228.
40. Ren K., Williams G. M., Hylden L. K., Ruda M. A. and Dubner R. (1992) The intrathecal administration of excitatory amino-acid antagonists selectively attenuates carrageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmac. 219, 235-243.
41. Rowan S., Todd A. J. and Spike R. C. (1993) Evidence that neuropeptide Y is present in GABAergic neurons in the superficial dorsal horn of the rat spinal cord. Neuroscience 53, 537-545.
42. Sawynok J. (1987) GABAergic mechanisms of analgesia; an update. Pharmac. Biochem. Behav. 26, 463-474.
43. Schaible H. G., Grubb B. D., Neugebauer V. and Oppmann M. (1991) The effects of NMDA antagonists on neuronal activity in cat spinal cord evoked by acute inflammation in the knee joint. Eur. J. Neurosci. 3, 981-991.
44. Seltzer Z., Cohn S., Ginzburg R. and Beilin B. (1991) Modulation of neuropathic pain in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 45, 69-75.
45. Sher G. and Mitchell D. (1990) N-Methyl-D-aspartate receptors mediate responses of rat dorsal horn neurones to hindlimb ischaemia. Brain Res. 522, 55-62.
46. - channels modulated by multiple drug-binding sites. Trends Pharm. Sci. 13, 446-451.
47. Simmons D. R., Spike R. C. and Todd A. J. (1995) Galanin is contained in GABAergic neurons in the rat spinal dorsal horn. Neurosci. Lett. 187, 119-122.
48. A and glycine receptors to central sensitization: Disinhibition and touch-evoked allodynia in the spinal cord. J. Neurophysiol. 72, 169-179.
49. Stanfa L. C., Dickenson A. H., Xu X.-J. and Wiesenfeld-Hallin Z. (1994) Cholecystokinin and morphine analgesia: Variations on a theme. Trends Pharm. Sci. 15, 65-66.
50. Stanfa L. C., Sullivan A. F. and Dickenson A. H. (1992) Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan induced inflammation. Pain 50, 345-354.
51. Taylor B. K., Peterson M. A. and Basbaum A. I. (1995) Persistent cardiovascular and behavioral responses to subcutaneous formalin require peripheral nerve input. J. Neurosci. 15, 7575-7584.
52. Todd A. J. and McKenzie J. (1989) GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience 31, 799-806.
53. Todd A. J. and Spike R. C. (1992) Immunohistochemical evidence that Met-enkephalin and GABA coexist in some neurones in rat dorsal horn. Brain Res. 584, 149-156.
54. Todd A. J., Watt C., Spike R. C. and Sieghart W. (1996) Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J. Neurosci. 16, 974-982.
55. Tölle T. R., Castro-Lopes J. M., Evan G. and Zieglgänsberger W. (1991) c-Fos induction in the spinal cord following noxious stimulation: Prevention by opiates but not by NMDA antagonists In Proceedings of the IVth World Congress on Pain. (Edited by Bond, Charlton and Woolf), p. 299. Elsevier, Amsterdam.
56. Vaccarino A. L., Marek P., Kest B., Weber E., Keana J. F. and Liebeskind J. C. (1993) NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res. 615, 331-334.
57. Watkins J. and Collingridge G. (1994) Phenylglycine derivative as antagonists of metatotropic glutamate receptors. Trends Pharm. Sci. 15, 333-342.
58. Woolf C. J. and Thompson S. W. N. (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury hypersensitivity states. Pain 44, 293-299.
59. Yaksh T. L. (1989) Behavioural and autonomie correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 37, 111-123.
60. Yamamoto T. and Yaksh T. L. (1992a) Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77, 757-763.
61. Yamamoto T. and Yaksh T. L. (1992b) Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci. Lett. 135, 67-70.
62. Yamamoto T. and Yaksh T. L. (1993) Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801. Pain 54, 79-84.